Martin Fan
Stock Analyst at Wedbush
(4.84)
# 76
Out of 5,093 analysts
15
Total ratings
78.57%
Success rate
58.71%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Martin Fan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VOR Vor Biopharma | Assumes: Neutral | $9 | $8.36 | +7.66% | 1 | Nov 25, 2025 | |
| IMA ImageneBio | Assumes: Underperform | $2 | $6.54 | -69.42% | 1 | Nov 25, 2025 | |
| ANAB AnaptysBio | Reiterates: Outperform | $50 | $44.52 | +12.31% | 4 | Nov 24, 2025 | |
| SANA Sana Biotechnology | Maintains: Outperform | $5 → $6 | $4.63 | +29.59% | 2 | Nov 7, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Outperform | $18 → $23 | $3.08 | +646.75% | 2 | Oct 17, 2025 | |
| ZBIO Zenas BioPharma | Maintains: Outperform | $35 → $40 | $39.37 | +1.61% | 2 | Oct 9, 2025 | |
| RNAC Cartesian Therapeutics | Initiates: Outperform | $38 | $6.72 | +465.48% | 1 | Jul 9, 2025 | |
| ACRS Aclaris Therapeutics | Initiates: Outperform | $8 | $3.28 | +143.90% | 1 | May 28, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Outperform | $40 | $31.45 | +27.21% | 1 | May 15, 2025 |
Vor Biopharma
Nov 25, 2025
Assumes: Neutral
Price Target: $9
Current: $8.36
Upside: +7.66%
ImageneBio
Nov 25, 2025
Assumes: Underperform
Price Target: $2
Current: $6.54
Upside: -69.42%
AnaptysBio
Nov 24, 2025
Reiterates: Outperform
Price Target: $50
Current: $44.52
Upside: +12.31%
Sana Biotechnology
Nov 7, 2025
Maintains: Outperform
Price Target: $5 → $6
Current: $4.63
Upside: +29.59%
Artiva Biotherapeutics
Oct 17, 2025
Maintains: Outperform
Price Target: $18 → $23
Current: $3.08
Upside: +646.75%
Zenas BioPharma
Oct 9, 2025
Maintains: Outperform
Price Target: $35 → $40
Current: $39.37
Upside: +1.61%
Cartesian Therapeutics
Jul 9, 2025
Initiates: Outperform
Price Target: $38
Current: $6.72
Upside: +465.48%
Aclaris Therapeutics
May 28, 2025
Initiates: Outperform
Price Target: $8
Current: $3.28
Upside: +143.90%
Oruka Therapeutics
May 15, 2025
Reiterates: Outperform
Price Target: $40
Current: $31.45
Upside: +27.21%